Journal of Molecular and Cellular Cardiology

The Journal of Molecular and Cellular Cardiology is a monthly journal published by Elsevier on behalf of the International Society for Heart Research, founded in 1970, with a 2025 impact factor of 4.9（Journal of Molecular and Cellular Cardiology）是由（Elsevier）代表国际心脏研究会（ISHR）出版的月刊，1970 年创办，2025 年影响因子为 4.9。

Scope

• The journal advances understanding of the mechanisms of normal and pathological cardiovascular function该刊致力于推进对正常与病理心血管功能机制的认识。
• It covers structural biology, genetics, proteomics, morphology, stem cells, molecular biology and metabolism内容涵盖结构生物学、遗传学、蛋白质组学、形态学、干细胞、分子生物学与代谢。
• Biophysics, bioengineering, computational modelling and systems analysis, electrophysiology, pharmacology and physiology are included生物物理、生物工程、计算建模与系统分析、电生理、药理学与生理学亦被涵盖。
• The journal emphasises research into underlying mechanisms rather than descriptive studies该刊重视对底层机制的研究，而非描述性研究。
• Cellular and molecular approaches to cardiac and vascular biology form its core细胞与分子层面的心脏与血管生物学研究构成其核心。

History

• The journal was founded in 1970 and was originally published by Academic Press该刊 1970 年创办，最初由（Academic Press）出版。
• It has been published for the International Society for Heart Research since January 1987自 1987 年 1 月起，该刊为国际心脏研究会出版。
• It is published by Elsevier该刊由（Elsevier）出版。
• A companion journal, JMCC Plus, was launched in 2022 as a fully open access title姊妹刊（JMCC Plus）于 2022 年创办，为完全开放获取期刊。

Editors

• Lorrie Kirshenbaum of the University of Manitoba in Canada is the editor-in-chief现任主编为加拿大（University of Manitoba）的 Lorrie Kirshenbaum。
• Rong Tian of the University of Washington served as editor-in-chief from 2020 and handed over in 2025（University of Washington）的 Rong Tian 自 2020 年起任主编，于 2025 年交棒。
• Davor Pavlovic of the University of Birmingham edits the companion journal JMCC Plus（University of Birmingham）的 Davor Pavlovic 主持姊妹刊（JMCC Plus）。
• The main journal uses hybrid open access, while JMCC Plus is fully open access主刊采用混合开放获取，姊妹刊（JMCC Plus）则为完全开放获取。